Aquestive Therapeutics Inc (AQST)
4.51
-0.22
(-4.75%)
USD |
NASDAQ |
Nov 21, 16:00
4.55
+0.04
(+0.89%)
Pre-Market: 08:25
Aquestive Therapeutics Debt to Equity Ratio: -0.6886 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.6886 |
| June 30, 2024 | -0.8464 |
| March 31, 2024 | -0.7929 |
| December 31, 2023 | -0.2585 |
| September 30, 2023 | -0.3805 |
| June 30, 2023 | -0.3672 |
| March 31, 2023 | -0.3881 |
| December 31, 2022 | -0.4399 |
| September 30, 2022 | -0.4906 |
| June 30, 2022 | -0.556 |
| March 31, 2022 | -0.5824 |
| December 31, 2021 | -0.6523 |
| September 30, 2021 | -0.6695 |
| June 30, 2021 | -0.7294 |
| Date | Value |
|---|---|
| March 31, 2021 | -0.7347 |
| December 31, 2020 | -0.761 |
| September 30, 2020 | -1.700 |
| June 30, 2020 | -2.876 |
| March 31, 2020 | -2.925 |
| December 31, 2019 | -9.856 |
| September 30, 2019 | -1.735 |
| June 30, 2019 | -1.924 |
| March 31, 2019 | -7.859 |
| December 31, 2018 | 4.683 |
| September 30, 2018 | 1.996 |
| June 30, 2018 | -1.192 |
| March 31, 2018 | -2.014 |
| December 31, 2017 | -1.718 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-9.856
Minimum
Dec 2019
-0.2585
Maximum
Dec 2023
-1.335
Average
-0.679
Median
Debt to Equity Ratio Benchmarks
| Rockwell Medical Inc | 0.3038 |
| Cormedix Inc | 0.00 |
| Axogen Inc | 0.4755 |
| NovaBay Pharmaceuticals Inc | 0.0476 |
| Palatin Technologies Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 109.96M |
| Total Liabilities (Quarterly) | 155.38M |
| Shareholders Equity (Quarterly) | -45.42M |
| Current Ratio | 6.373 |
| Net Debt Paydown Yield | 0.35% |